-
公开(公告)号:US20120040896A1
公开(公告)日:2012-02-16
申请号:US12937217
申请日:2009-04-13
IPC分类号: A61K38/17 , A61K38/30 , A61P35/00 , A61K31/404 , A61K31/663 , C07K16/18 , A61K38/28
CPC分类号: C07K16/18
摘要: Embodiments of the present invention generally relate to methods, compositions and uses for diagnosis and treatment of cancer. Certain embodiments report methods and compositions for diagnosing and/or treating a subject having a BRCA1-related cancer or sporadic cancer. Some embodiments disclose treatments that can include, but are not limited to, modulation of BRCA1. In some embodiments, methods for identifying a subject with unstable BRCA1 protein are reported.
摘要翻译: 本发明的实施方案一般涉及用于诊断和治疗癌症的方法,组合物和用途。 某些实施方案报道了用于诊断和/或治疗患有BRCA1相关癌症或散发性癌症的受试者的方法和组合物。 一些实施方案公开了可以包括但不限于调节BRCA1的治疗。 在一些实施方案中,报告了用于鉴定具有不稳定BRCA1蛋白的受试者的方法。